Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East
Objective: The purpose of this paper is to review the efficacy and safety profile in children treated with topical 0.03% Tacrolimus ointment for vernal keratoconjunctivitis in Middle East and to propose a treatment posology. According to recent studies, a complex non-IgE dependent mechanism plays a...
Main Authors: | Sandra Flavia Fiorentini, Darakhshanda Khurram |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-04-01
|
Series: | Saudi Journal of Ophthalmology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319453418301747 |
Similar Items
-
COMPARATIVE EVALUATION OF TACROLIMUS 0.03% OINTMENT VS OLOPATADINE 0.2% EYE DROPS IN THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS
by: Hassan Sajjad Rathore, et al.
Published: (2021-02-01) -
Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
by: Abdulrahman Mohammed Al-Amri, et al.
Published: (2017-01-01) -
Successful Treatment of Recalcitrant Granuloma Gluteale Infantum with Topical Tacrolimus 0.03% Ointment
by: Alexander K. C. Leung, et al.
Published: (2021-01-01) -
Long-term use of topical tacrolimus ointment: a safe and effective option for the treatment of vernal keratoconjunctivitis
by: Guilherme Gubert Müller, et al.
Published: (2019-01-01) -
Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis
by: Shoughy SS, et al.
Published: (2016-04-01)